(Q46579864)

23 December 2017

title

Effects of the selective EP4 antagonist, CJ-023,423 on chronic inflammation and bone destruction in rat adjuvant-induced arthritis (English)

1 reference

23 December 2017

author name string

Takako Okumura

1

1 reference

23 December 2017

Yoko Murata

2

1 reference

23 December 2017

Kana Taniguchi

3

1 reference

23 December 2017

Akio Murase

4

1 reference

23 December 2017

Aisuke Nii

5

1 reference

23 December 2017

publication date

1 June 2008

1 reference

23 December 2017

Journal of Pharmacy and Pharmacology

published in

1 reference

23 December 2017

volume

60

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

723-730

1 reference

23 December 2017

Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.6.0007

Novel cyclooxygenase-catalyzed bioactive prostaglandin F2alpha from physiology to new principles in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.6.0007

Prostanoid receptors: subtypes and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.6.0007

Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.6.0007

Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.6.0007

The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.6.0007

CJ-023,423, a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.6.0007

Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.6.0007

The role of osteoprotegerin in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.6.0007

Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.6.0007

Immune regulation in adjuvant-induced arthritis: possible implications for innovative therapeutic strategies in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.6.0007

Piglet saphenous vein contains multiple relaxatory prostanoid receptors: evidence for EP4, EP2, DP and IP receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.6.0007

GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.60.6.0007

21 January 2018

Identifiers

DOI

10.1211/JPP.60.6.0007

1 reference

23 December 2017

1 reference

23 December 2017